Safety, Feasibility, and Rifapentine Plasma Concentration in Chinese Children With 1 Month of Daily Rifapentine Plus Isoniazid for Tuberculosis Infection
Authors
Shuihua Lu (ORCID: https://orcid.org/0000-0002-2625-7686)
Safety, Feasibility, and Rifapentine Plasma Concentration in Chinese Children With 1 Month of Daily Rifapentine Plus Isoniazid for Tuberculosis Infection
Shuihua Lu, Jianfeng Zeng, Wei Li, Peize Zhang et al.
Journal
Clinical Infectious Diseases
Topics
Pharmacological Effects and Toxicity Studies
article
Safety, Feasibility, and Rifapentine Plasma Concentration in Chinese Children With 1 Month of Daily Rifapentine Plus Isoniazid for Tuberculosis Infection
Southern University of Science and Technology (CN), Center for Tuberculosis Control of Guangdong Province (CN), National Clinical Research (US), Shenzhen Third People’s Hospital (CN)